BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25365795)

  • 21. [The clinical application of diffusion weighted magnetic resonance imaging to acute cerebrovascular disorders].
    Chu BC; Miyasaka K
    No To Shinkei; 1998 Sep; 50(9):787-95. PubMed ID: 9789301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deep white matter pathologic features in watershed regions: a novel pattern of central nervous system involvement in MELAS.
    Apostolova LG; White M; Moore SA; Davis PH
    Arch Neurol; 2005 Jul; 62(7):1154-6. PubMed ID: 16009776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ketoacidosis accompanied by epileptic seizures in a patient with diabetes mellitus and mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS).
    Nakamura S; Yoshinari M; Wakisaka M; Kodera H; Doi Y; Yoshizumi H; Asano T; Iwase M; Mihara F; Fujishima M
    Diabetes Metab; 2000 Nov; 26(5):407-10. PubMed ID: 11119021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral hyperperfusion and decreased cerebrovascular reactivity correlate with neurologic disease severity in MELAS.
    Rodan LH; Poublanc J; Fisher JA; Sobczyk O; Wong T; Hlasny E; Mikulis D; Tein I
    Mitochondrion; 2015 May; 22():66-74. PubMed ID: 25801712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perfusion status of the stroke-like lesion at the hyperacute stage in MELAS.
    Yeh HL; Chen YK; Chen WH; Wang HC; Chiu HC; Lien LM; Wei YH
    Brain Dev; 2013 Feb; 35(2):158-64. PubMed ID: 22516515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MELAS: Clinical and pathologic correlations with MRI, xenon/CT, and MR spectroscopy.
    Clark JM; Marks MP; Adalsteinsson E; Spielman DM; Shuster D; Horoupian D; Albers GW
    Neurology; 1996 Jan; 46(1):223-7. PubMed ID: 8559380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MR imaging in the assessment of response to radiotherapy of lytic bone metastases from breast cancer.
    Gaeta M; Benedetto C; Minutoli F; D'Angelo T; Amato E; Mazziotti S; Racchiusa S; Mormina E; Blandino A; Pergolizzi S
    Acad Radiol; 2014 Oct; 21(10):1286-93. PubMed ID: 25088834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regression of stroke-like lesions in MELAS-syndrome after seizure control.
    Finsterer J; Barton P
    Epileptic Disord; 2010 Dec; 12(4):330-4. PubMed ID: 21059492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focal cerebellar infarction as an initial sign of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
    Ko A; Lee SJ; Lee YM
    J Inherit Metab Dis; 2019 May; 42(3):575-576. PubMed ID: 30693531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focal hyperperfusion in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Case report.
    Amagasaki K; Shimizu T; Suzuki Y; Kakizawa T
    J Neurosurg; 2001 Jan; 94(1):133-6. PubMed ID: 11147883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late-onset mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes with bitemporal lesions.
    Kisanuki YY; Gruis KL; Smith TL; Brown DL
    Arch Neurol; 2006 Aug; 63(8):1200-1. PubMed ID: 16908753
    [No Abstract]   [Full Text] [Related]  

  • 32. Serial diffusion-weighted imaging in a patient with MELAS and presumed cytotoxic oedema.
    Wang XY; Noguchi K; Takashima S; Hayashi N; Ogawa S; Seto H
    Neuroradiology; 2003 Sep; 45(9):640-3. PubMed ID: 12898076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased brain perfusion contrast with T₂-prepared intravoxel incoherent motion (T2prep IVIM) MRI.
    Federau C; O'Brien K
    NMR Biomed; 2015 Jan; 28(1):9-16. PubMed ID: 25303668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Auditory symptoms: a critical clue for diagnosis of MELAS.
    Tawankanjanachot I; Channarong NS; Phanthumchinda K
    J Med Assoc Thai; 2005 Nov; 88(11):1715-20. PubMed ID: 16471125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiologic evaluation of MELAS strokes by serially quantified MRS and CASL perfusion images.
    Tsujikawa T; Yoneda M; Shimizu Y; Uematsu H; Toyooka M; Ikawa M; Kudo T; Okazawa H; Kuriyama M; Kimura H
    Brain Dev; 2010 Feb; 32(2):143-9. PubMed ID: 19171446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serial diffusion-weighted imaging in MELAS.
    Ohshita T; Oka M; Imon Y; Watanabe C; Katayama S; Yamaguchi S; Kajima T; Mimori Y; Nakamura S
    Neuroradiology; 2000 Sep; 42(9):651-6. PubMed ID: 11071437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paralytic ileus in MELAS with phenotypic features of MNGIE.
    Chang TM; Chi CS; Tsai CR; Lee HF; Li MC
    Pediatr Neurol; 2004 Nov; 31(5):374-7. PubMed ID: 15519124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes with magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Feng F; You H; Gao J; Li XZ; Meng CL; Sun HY; Jin ZY; Guo YP
    Chin Med Sci J; 2006 Dec; 21(4):234-8. PubMed ID: 17249198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [MELAS--mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome--two cases confirmed by biochemical and molecular investigations. Differential diagnosis of stroke causes].
    Mierzewska H; Mroczek K; Pronicki M; Pronicka E; Karczmarewicz E; Bartnik E; Zdzienicka E; Seniów J; Schmidt-Sidor B; Taraszewska A; Palasik W
    Neurol Neurochir Pol; 2002; 36(3):457-70. PubMed ID: 12185802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial myopathy-encephalopathy-lactic acidosis-and strokelike episodes (MELAS) syndrome: CT and MR findings in seven children.
    Kim IO; Kim JH; Kim WS; Hwang YS; Yeon KM; Han MC
    AJR Am J Roentgenol; 1996 Mar; 166(3):641-5. PubMed ID: 8623642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.